Fraser Brims
Fraser Brims writes for The Conversation on lung cancer screening and respiratory health, using his chest medicine and research background to examine how early detection programs interact with the capacity of the health system.
Lung cancer screening and health system capacity
Brims’ recent coverage centres on Australia’s national lung cancer screening program and whether the health system can sustain what screening promises to deliver. In his analysis of the program a year after its launch, he focuses on how structured screening for high‑risk groups is intended to shift diagnoses towards earlier stages and reduce mortality, while testing the readiness of existing services to absorb new demand. He writes from the standpoint of a clinician and researcher who works directly with lung cancer pathways and program design, drawing on his involvement in research funded by major health and cancer agencies and on his leadership role in work associated with Australia’s lung cancer screening initiative. The result is coverage that explains the rationale for screening, outlines how it is being implemented, and probes the practical limits of workforce, infrastructure and follow‑up care when policy meets clinical reality.
Respiratory disease, early detection and clinical guidelines
Outside The Conversation, Brims’ published work shows a sustained focus on diseases that underpin his commentary on screening and respiratory care. He has written extensively on malignant pleural mesothelioma, detailing its epidemiology, latency after asbestos exposure, familial risk and the factors that shape prognosis. He is a lead contributor to clinical guidance on the management of incidental pulmonary nodules, setting out practical pathways for assessing nodule change over time, deciding when to biopsy or operate, and organising multidisciplinary review for suspected early lung cancers. This combination of mesothelioma research and lung nodule guideline work informs his public writing on lung cancer by grounding policy discussion in the day‑to‑day questions of how suspicious findings are investigated, how risk is balanced against invasive procedures, and how early detection efforts translate into outcomes for patients.
Advance care planning and the patient experience of respiratory illness
Brims also contributes to studies on advance care planning for people with advanced respiratory disease, examining how structured, nurse‑led discussions affect whether patients document their preferences and talk about life‑sustaining treatments with family and clinicians. His work in this area shows that facilitated conversations increase both formal documentation and informal discussions about future care, and that symptom burden, readiness to engage and social support all shape how patients take up these opportunities. This research perspective adds a patient‑centred dimension to his coverage of respiratory health, linking system‑level policies such as screening to the lived experience of people managing severe lung disease and the importance of integrating prognosis, treatment options and personal values.
Evidence‑based commentary on medical research and systems
Brims’ broader academic record includes analysis of the state of medical research, such as work on whether research activity within the UK is in decline, which looks at trends in publications and funding across specialties. Alongside his clinical and guideline writing, this systems‑oriented research underpins his approach to public commentary: he writes as an academic clinician who is attentive to how health services, research investment and national programs intersect. Across his journalism and research outputs he maintains a through‑line of evidence‑based explanation, connecting policy decisions on lung cancer and respiratory care with detailed knowledge of disease behaviour, diagnostic pathways and patient priorities.
4 more health journalists.
Abida Tasnim
Abida Tasnim is a health writer for The Daily Star who focuses on clear, practical guidance that helps readers recognise risks early and act before everyday illnesses turn into wider public health problems. She reports on infectious disease prevention, using measles coverage to show how outbreaks start with individual decisions and behaviours, not just hospital statistics. Her work explains what happens during an outbreak and then anchors the story in simple steps people can take, such as avoiding crowded places when symptoms appear, practising good hygiene, and seeking medical advice early. She writes direct, action‑oriented health explainers that turn clinical questions about contagion and disease burden into everyday choices. Across her beat, she stresses early recognition, timely care, and prevention as the foundations of healthier communities.
Adrián Carballo Casla
Adrián Carballo Casla stands out for turning complex cohort data on ageing into clear, food‑level advice on what older adults should eat to protect brain health and slow chronic disease. He is a researcher in nutritional epidemiology focused on ageing and chronic disease prevention and a postdoctoral researcher in geriatric epidemiology at Karolinska Institutet, writing health explainers for The Conversation. He reports on how diet quality, especially Mediterranean and Mind‑style patterns, shapes dementia risk, grey matter loss and neurocognitive ageing, and how healthy versus pro‑inflammatory diets alter multimorbidity trajectories. His articles translate findings on flavonoids, polyphenols, folate, omega‑3 fats and dietary nitrates into specific food choices and small, practical changes. Much of his coverage is anchored in his own studies on multimorbidity, high‑risk older adults and tailored dietary recommendations, often syndicated to other outlets.
Ahmed Elbediwy
Ahmed Elbediwy brings a lab-based understanding of cancer biology and clinical biochemistry to public-facing health reporting, linking drug mechanisms and molecular pathways to everyday choices about medicines and products. He writes for The Conversation on weight-loss injections, cancer overdiagnosis and anti-ageing supplements, focusing on obesity medicine, cancer signalling, screening trade-offs, skincare and supplement science. His pieces on GLP-1 drugs such as Ozempic, Wegovy and Mounjaro explain why some people do not respond, how gut hormones and appetite signals work, and where psychological support and nutrition fit alongside prescriptions. He co-authors explainers on cancer risk and overdiagnosis and on whether supplements can reverse ageing, separating established knowledge from emerging research. An award-winning senior lecturer at Kingston University, he favours clear, structured explainers, careful definition of key terms and evidence-based appraisal over hype.
Amanda Sheppeard
Amanda Sheppeard is a managing editor and health journalist known for long, detailed explainers that connect complex clinical research, disability policy and political narratives with the daily realities of doctors and patients. She works at The Medical Republic across editorial leadership and commercial content while reporting widely on medicine for its specialist titles. Her real beat spans autism, disability policy, autoimmune disease, infectious threats and system pressures in primary care and hospitals. She covers subjects such as autism diagnosis and the NDIS, rheumatology’s clinical shifts, weight-loss agents in rheumatoid arthritis, infection control, antimicrobial resistance and new modalities like CAR T-cell therapy and microneedles. She reports by doing the synthesis inside the story, linking trial design, molecular targets, funding rules and policy changes to concrete decisions and workflows in clinics and hospitals.